NanoPhoria Bioscience
PrivateLast Round
Series A
Oct 6, 2025
Total Funding Raised
$121.65M
Company Overview
NanoPhoria Bioscience operates in Healthcare & Life Sciences and is based in Milan. Its latest recorded funding round was a Series A round in October 2025.
NanoPhoria Bioscience is a biopharmaceutical company developing a non-viral drug delivery platform using inorganic nanoparticles to provide treatments for heart failure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoPhoria Bioscience Comparables
Compare NanoPhoria Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AaviGen | 70% | |
| Philip Morris International | 67% | |
| Phoreus Biotechnology, Inc. | 66% |
For institutional investors. Book with your work email.
NanoPhoria Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 6, 2025 | ||||
| Grant | Feb 25, 2025 | ||||
| Seed | May 11, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NanoPhoria Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series A, Grant |
| XGEN Venture | Series A |
| CDP Venture Capital SGR | Series A |
| Panakès Partners | Series A |
| Sofinnova Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Grew 33% QoQ from 12 to 16 employees.
- Oct 6, 2025
$98M round led by CDP Venture Capital SGR, Sofinnova Partners, and XGEN Venture.
For institutional investors. Book with your work email.
NanoPhoria Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NanoPhoria Bioscience's valuation, stock price, and market status.
Is NanoPhoria Bioscience a public or private company?
NanoPhoria Bioscience is a private company.
What is the current stock price of NanoPhoria Bioscience?
NanoPhoria Bioscience is a private company, so its shares have no public market price. Caplight tracks NanoPhoria Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NanoPhoria Bioscience worth (valuation)?
Valuation information for NanoPhoria Bioscience is not publicly available.
Can I buy NanoPhoria Bioscience stock?
NanoPhoria Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NanoPhoria Bioscience's last funding round?
NanoPhoria Bioscience's most recent funding round was Series A on October 6, 2025.
Who are the main investors in NanoPhoria Bioscience?
Key investors in NanoPhoria Bioscience include XGEN Venture, CDP Venture Capital SGR, Sofinnova Partners.
Will NanoPhoria Bioscience IPO soon?
No public IPO plans have been announced for NanoPhoria Bioscience.
How can I track NanoPhoria Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in NanoPhoria Bioscience's shares on secondary markets.